Related Experiment Video
Updated: Sep 2, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 10, 2011
Prevalence of methicillin-resistant Staphylococcus aureus in a dermatology outpatient population
M F Price1, M E McBride, J E Wolf
1Infectious Disease Section, St. Luke's Episcopal Hospital, Baylor College of Medicine, Houston, Tex 77030, USA.
Background:
The number of methicillin-resistant STaphylococcus aureus (MRSA) infections in the hospital setting is increasing but little is known of its prevalence in the community. In a 1986-1987 study, the prevalence in dermatology outpatient clinics was <0.9%. This study reports changes in the same facilities from 1988 through 1996.
Methods:
Culture results and antimicrobial susceptibility patterns were reviewed for the population for the period 1988 through 1996.
Results:
We report a gradual increase of MRSA from 1.5% of all strains of Staphylococcus aureus in 1988 to 11.9% in 1996 in these outpatient facilities. Susceptibility data indicate that the MRSA strains isolated in 1996 are more resistant to oral agents such as ciprofloxacin and tetracycline, while all strains remain susceptible to the intravenous agent vancomycin.
Conclusion:
The prevalence of MRSA in the community is increasing and should be considered when selecting a treatment regimen for staphylococcal infections.
Insights
Community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections are rising. This study tracked MRSA prevalence in outpatient dermatology clinics from 1988 to 1996, revealing a significant increase.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections are increasing.
- Limited data exists on MRSA prevalence in community settings.
- Previous studies indicated a low prevalence (<0.9%) in dermatology outpatient clinics in 1986-1987.
Purpose of the Study:
- To assess the changing prevalence of MRSA in community dermatology outpatient facilities.
- To analyze antimicrobial susceptibility patterns of MRSA isolates over time.
Main Methods:
- Retrospective review of culture results.
- Analysis of antimicrobial susceptibility patterns.
- Data collected from 1988 through 1996 in dermatology outpatient facilities.
Main Results:
- MRSA prevalence increased from 1.5% in 1988 to 11.9% in 1996.
- MRSA strains in 1996 showed increased resistance to oral agents like ciprofloxacin and tetracycline.
- All MRSA strains remained susceptible to intravenous vancomycin.
Conclusions:
- MRSA prevalence in the community is increasing.
- Consider MRSA when choosing treatment for staphylococcal infections.
- The rise in community MRSA necessitates updated treatment guidelines.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
The Skin Microbiota
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

